ACTrans · Accelerating Clinical Translation. Charting the Politics of Translation in the European Union
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2018-02-12 → 2020-03-13
- Финансиране от ЕС
- 160 800 €
- Участници
- 1
- Схема
- MSCA-IF-EF-ST
Линиите свързват координатора с партньорите.
Накратко на български
Политиките на ЕС за превръщане на биомедицинските открития в реални продукти, като например нови цифрови технологии за здраве, се анализират от социална и политическа гледна точка. Това помага за разбирането на пречките пред развитието на европейското общество на знанието.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Accelerating Clinical Translation. Charting the Politics of Translation in the European Union
The project has focused on studying the social and political implications of the regulatory and policy initiatives put in place by the European Union (EU) to remove the barriers hindering the translation of scientific findings into tangible innovation outcomes within the continent. The acceleration of biomedical innovation – which is increasingly based on data-intensive digital practices and technologies – has emerged as a foremost policy objective of the Union in recent years. Yet, whilst their beneficial consequences are mostly taken to be self-evident, a number of challenges characterize the pursuit of innovation-driven research practices in the biomedical domain. This project set out to investigate, scrutinize and critically discuss such challenges. Notably, the project has pursued three parallel objectives. First, to chart how ‘translation’ is framed and articulated in EU regulatory and science policy. Secondly, to empirically investigate and tease out the sociotechnical dynamics underpinning regulatory and policy initiatives geared to accelerate biomedical innovation. Thirdly, to critically assess the socio–political import of translational initiatives in the political macro–area of the EU. Given the increased emphasis placed by policymakers upon biomedical innovation policies as one of the privileged means to advance a European knowledge-intensive society and economy, this project has covered a theme of significant social and political relevance, and could bring its findings to bear on major policy discussions and initiatives at the national and European level.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
In the post–genomic era, innovation policies in biomedicine are increasingly being driven by the notion that constant advancements in biological knowledge fail to materialize into tangible therapeutic outcomes. Discursively framed in terms of a “gap” between “bench” and “bedside” in need of urgent “bridging”, this representation of the shortcomings of biomedical innovation has propelled growing efforts tailored towards the clinical translation of research results. In the European Union, the acceleration of clinical translation has been positioned as a cornerstone of its innovation strategy, as attested by the launch of a host of translational policy initiatives and a vast array of regulatory reforms in the process of medicines approval.However, in spite of its growing relevance, the broader expectations, dynamics and implications of the translational enterprise at EU level have yet to be comprehensively drawn out by the social sciences. This project sets out to accomplish this objective. Drawing from qualitative research methodologies, it investigates the articulation of translational initiatives in the policy and regulatory context of the EU, with the aim to chart and analyze the different epistemic and normative expectations underpinning translational policies, the sociotechnical dynamics of their implementation, as well as their social and political implications. Specifically, the project focuses on the mobilization of translational initiatives into the service of EU socio–political consolidation and its transboundary exercise of political, economic and cultural power, and will investigate the possible tensions and trade–offs between the political ideal of competitiveness enshrined in such initiatives, and those of democratic accountability and social justice.
Оригинален текст от CORDIS (на английски).
Участници
- KATHOLIEKE UNIVERSITEIT LEUVEN · LeuvenКоординаторБелгия
Връзки
- Виж в CORDIS
- DOI: 10.3030/753531
- https://soc.kuleuven.be/ceso/life-sciences-society-lab/accelerating-clinical-translation-charting-the-politics-of-biomedical-innovation-in-the-european-union
Данни: CORDIS, © Европейски съюз
